Does arousal frequency predict daytime function?
R N Kingshott, H M Engleman, I J Deary, N J Douglas, R N Kingshott, H M Engleman, I J Deary, N J Douglas
Abstract
Patients with the sleep apnoea/hypopnoea syndrome (SAHS) have impaired daytime function with demonstrable sleepiness and impaired cognition. The hypothesis that brief arousals from sleep cause these daytime impairments was tested. One hundred and fifty patients with sleep disordered breathing were studied prospectively, comparing overnight polysomnography with daytime measures of objective sleepiness, psychological well-being and cognitive performance. Significant, but weak (r2<0.1), relationships were seen between several nocturnal measures (apnoea/hypopnoea index, arousals and desaturation variables) and daytime measures of quality of life, well-being, subjective sleepiness, symptoms and cognitive performance. The only significant relationship between nocturnal variables and objective sleepiness was a very weak correlation (r2<0.05) between the lowest oxygen saturation and mean maintenance of wakefulness test (MWT) result. The MWT was better correlated with daytime function than the multiple sleep latency test. This study shows a lack of strong relationships between conventional nocturnal measures and daytime function in patients with sleep disordered breathing.
Source: PubMed
Prochains essais cliniques
-
NCT07826949Pas encore de recrutementGliome | Tumeur cérébrale | Gliomes récurrents de haut grade
-
NCT07826962Pas encore de recrutementParticipation des patients
-
NCT07826975Pas encore de recrutement
-
NCT07826988Pas encore de recrutementDrépanocytose | Crise vaso-occlusive
-
NCT07827001RecrutementCancer du cerveau | Cancer du SNC | Cancer du système nerveux | Cancer du cerveau métastatique
-
NCT07827027Pas encore de recrutement
-
NCT07827040RecrutementAdultes | Assistance numérique basse vision | Troubles de la vision
-
NCT07827053Pas encore de recrutementAdénocarcinome canalaire pancréatique (PDAC)
-
NCT07827066Pas encore de recrutementSevrage tabagique | Agent IA | Early-Stage Cancer
-
NCT07827131Pas encore de recrutement